GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aclarion Inc (NAS:ACON) » Definitions » Price-to-Tangible-Book

Aclarion (Aclarion) Price-to-Tangible-Book : 1.77 (As of May. 29, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Aclarion Price-to-Tangible-Book?

As of today (2024-05-29), Aclarion's share price is $0.3248. Aclarion's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $0.18. Hence, Aclarion's Price to Tangible Book Ratio of today is 1.77.

The historical rank and industry rank for Aclarion's Price-to-Tangible-Book or its related term are showing as below:

ACON' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.7   Med: 2.96   Max: 4.49
Current: 1.8

During the past 5 years, Aclarion's highest Price to Tangible Book Ratio was 4.49. The lowest was 1.70. And the median was 2.96.

ACON's Price-to-Tangible-Book is ranked better than
70.95% of 475 companies
in the Healthcare Providers & Services industry
Industry Median: 3.08 vs ACON: 1.80

A closely related ratio is called PB Ratio. As of today, Aclarion's share price is $0.3248. Aclarion's Book Value per Sharefor the quarter that ended in Mar. 2024 was $0.35. Hence, Aclarion's P/B Ratio of today is 0.93.


Aclarion Price-to-Tangible-Book Historical Data

The historical data trend for Aclarion's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aclarion Price-to-Tangible-Book Chart

Aclarion Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - 4.49 -

Aclarion Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1.79

Competitive Comparison of Aclarion's Price-to-Tangible-Book

For the Health Information Services subindustry, Aclarion's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aclarion's Price-to-Tangible-Book Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aclarion's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Aclarion's Price-to-Tangible-Book falls into.



Aclarion Price-to-Tangible-Book Calculation

Aclarion's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.3248/0.184
=1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Aclarion Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Aclarion's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Aclarion (Aclarion) Business Description

Traded in Other Exchanges
N/A
Address
8181 Arista Place, Suite 300, Broomfield, CO, USA, 80021
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Executives
John Paul Lorbiecki officer: Chief Financial Officer 238 CHEYENNE DRIVE, LAFAYETTE CO 80026
Brent Ness director, officer: Chief Executive Officer 951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
Ryan Bond officer: Chief Strategy Officer 951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
Stephen Deitsch director 1600 BROADWAY, SUITE 700, DENVER CO 80202
William Wesemann director 130 MONTALVO ROAD, REDWOOD CITY CA 94062
Jeffrey John Thramann director, officer: Executive Chairman 8580 STRAWBERRY LANE, NIWOT CO 80503
Michael W Dirks 10 percent owner 811 EAST 30TH AVE, HUTCHINSON KS 67502
Nuvasive Inc 10 percent owner 7475 LUSK BLVD, SAN DIEGO CA 92121
Sc Capital 1 Llc 10 percent owner 1 COMPOUND DRIVE, HUTCHINSON KS 67502
Scott Breidbart director 951 MARINERS ISLAND BLVD, SUITE 300, SAN MATEO CA 94404
Amanda Mae Sequira director 951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO CA 94404
David K Neal director C/O ACLARION, INC., 951 MARINERS ISLAND BLVD, SUITE 300, SAN MATEO CA 94404

Aclarion (Aclarion) Headlines

From GuruFocus

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

By Stock market mentor Stock market mentor 01-17-2023

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor

By Stock market mentor Stock market mentor 01-31-2023